Mass spectrometry-based proteomic analysis of middle-aged vs. aged vastus lateralis reveals increased levels of carbonic anhydrase isoform 3 in senescent human skeletal muscle

International Journal of Molecular Medicine

Volumn 30, Issue 4, 2012, Pages 723-733

  Staunton, Lisa ^a   Zweyer, Margit ^b   Swandulla, Dieter ^b   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Aging; Carbonic anhydrase isoform 3; Difference in gel electrophoresis; Sarcopenia; Vastus lateralis

Indexed keywords

CARBONATE DEHYDRATASE III;

ADULT; AGED; ARTICLE; CELL STRESS; FLUORESCENCE; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE METABOLISM; MUSCLE RELAXATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE;

AGED; AGED, 80 AND OVER; AGING; AMINO ACID SEQUENCE; CARBONIC ANHYDRASE III; HUMANS; IMMUNOBLOTTING; MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEOME; PROTEOMICS; QUADRICEPS MUSCLE;

EID: 84866519385     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1056     Document Type: Article

References (85)

1. Vijg J and Wei JY: Understanding the biology of aging: the key to prevention and therapy. J Am Geriatr Soc 43: 426-434, 1995.
2. Flatt T and Schmidt PS: Integrating evolutionary and molecular genetics of aging. Biochim Biophys Acta 1790: 951-962, 2009.
3. Kirkwood TB and Austad SN: Why do we age? Nature 408: 233-238, 2000.
4. Kirkwood TB and Melov S: On the programmed/non-programmed nature of ageing within the life history. Curr Biol 21: R701-R707, 2011.
5. Lynch GS (ed): Sarcopenia - Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments. Springer, New York, p480, 2011.
6. Thompson LV: Age-related muscle dysfunction. Exp Gerontol 44: 106-111, 2009.
7. Evans WJ: Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr 91: 1123S-1127S, 2010.
8. Thomas DR: Sarcopenia. Clin Geriatr Med 26: 331-346, 2010.
9. Berger MJ and Doherty TJ: Sarcopenia: prevalence, mechanisms, and functional consequences. Interdiscip Top Gerontol 37: 94-114, 2010.
10. Forbes GB and Reina JC: Adult lean body mass declines with age: some longitudinal observations. Metabolism 19: 653-663, 1970.
11. + years of age. J Gerontol A Biol Sci Med Sci 50: M307-M316, 1995.
12. Lindle RS, Metter EJ, Lynch NA, Fleg JL, Fozard JL, Tobin J, Roy TA and Hurley BF: Age and gender comparisons of muscle strength in 654 women and men aged 20-93 yr. J Appl Physiol 83: 1581-1587, 1997. (Pubitemid 27495334)
13. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ and Lindeman RD: Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147: 755-763, 1998. (Pubitemid 28183275)
14. Melton LJ III, Khosla S, Crowson CS, O'Connor MK, O'Fallon WM and Riggs BL: Epidemiology of sarcopenia. J Am Geriatr Soc 48: 625-630, 2000. (Pubitemid 30390451)
15. Janssen I, Heymsfield SB and Ross R: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50: 889-896, 2002. (Pubitemid 34496687)
16. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M and Newman AB: The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61: 1059-1064, 2006. (Pubitemid 44727214)
17. Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, Boudreau R, Manini TM, Nevitt M, Newman AB and Goodpaster BH: Health, aging, and body. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 90: 1579-1585, 2009.
18. Hedayati KK and Dittmar M: Prevalence of sarcopenia among older community-dwelling people with normal health and nutritional state. Ecol Food Nutr 49: 110-128, 2010.
19. Patel HP, Syddall HE, Martin HJ, Stewart CE, Cooper C and Sayer AA: Hertfordshire sarcopenia study: design and methods. BMC Geriatr 10: 43, 2010.
20. Proctor DN, O'Brien PC, Atkinson EJ and Nair KS: Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol 277: E489-E495, 1999. (Pubitemid 29458209)
21. Vandervoort AA: Aging of the human neuromuscular system. Muscle Nerve 25: 17-25, 2002.
22. Frontera WR, Reid KF, Phillips EM, Krivickas LS, Hughes VA, Roubenoff R and Fielding FA: Muscle fiber size and function in elderly humans: a longitudinal study. J Appl Physiol 105: 637-642, 2008.
23. Faulkner JA, Larkin LM, Claflin DR and Brooks SV: Age-related changes in the structure and function of skeletal muscles. Clin Exp Pharmacol Physiol 34: 1091-1096, 2007. (Pubitemid 47416362)
24. Scott D, Blizzard L, Fell J and Jones G: The epidemiology of sarcopenia in community living older adults: what role does lifestyle play? J Cachexia Sarcopenia Muscle 2: 125-134, 2011.
25. Coker RH and Wolfe RR: Bedrest and sarcopenia. Curr Opin Clin Nutr Metab Care 15: 7-11, 2012.
26. Aagaard P, Suetta C, Caserotti P, Magnusson SP and Kjaer M: Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure. Scand J Med Sci Sports 20: 49-64, 2010.
27. Edstrom E, Altun M, Bergman E, Johnson H, Kullberg S, Ramirez-Leon V and Ulfhake B: Factors contributing to neuromuscular impairment and sarcopenia during aging. Physiol Behav 92: 129-135, 2007. (Pubitemid 47374254)
28. Beyer I, Mets T and Bautmans I: Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 15: 12-22, 2012.
29. Larsson L, Sjodin B and Karlsson J: Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22-65 years. Acta Physiol Scand 103: 31-39, 1978. (Pubitemid 8349314)
30. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, et al: Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) 'cachexia-anorexia in chronic wasting diseases' and 'nutrition in geriatrics'. Clin Nutr 29: 154-159, 2010.
31. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, et al; Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39: 412-423, 2010.
32. Cruz-Jentoft AJ, Landi F, Topinkova E and Michel JP: Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13: 1-7, 2010.
33. Patel H, Syddall HE, Martin HJ, Cooper C, Stewart C and Sayer AA: The feasibility and acceptability of muscle biopsy in epidemiological studies: findings from the Hertfordshire Sarcopenia Study (HSS). J Nutr Health Aging 15: 10-15, 2011.
34. Lexell J, Taylor CC and Sjostrom M: What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci 84: 275-294, 1988. (Pubitemid 18087270)
35. Lexell J: Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci 50: 11-16, 1995.
36. Lewis C, Doran P and Ohlendieck K: Proteomic analysis of dystrophic muscle. Methods Mol Biol 798: 357-369, 2012.
37. Ohlendieck K: Proteomics of skeletal muscle differentiation, neuromuscular disorders and fiber aging. Expert Rev Proteomics 7: 283-296, 2010.
38. Gelfi C, Vasso M and Cerretelli P: Diversity of human skeletal muscle in health and disease: contribution of proteomics. J Proteomics 74: 774-795, 2011.
39. Ohlendieck K: Skeletal muscle proteomics: current approaches, technical challenges and emerging techniques. Skelet Muscle 1: 6, 2011.
40. Doran P, Donoghue P, O'Connell K, Gannon J and Ohlendieck K: Proteomics of skeletal muscle aging. Proteomics 9: 989-1003, 2009.
41. Piec I, Listrat A, Alliot J, Chambon C, Taylor RG and Bechet D: Differential proteome analysis of aging in rat skeletal muscle. FASEB J 19: 1143-1145, 2005. (Pubitemid 40946445)
42. O'Connell K, Gannon J, Doran P and Ohlendieck K: Proteomic profiling reveals a severely perturbed protein expression pattern in aged skeletal muscle. Int J Mol Med 20: 145-153, 2007.
43. Doran D, Gannon J, O'Connell K and Ohlendieck K: Aging skeletal muscle shows a drastic increase in the small heat shock proteins αB-crystallin/ HspB5 and cvHsp/HspB7. Eur J Cell Biol 86: 629-640, 2007. (Pubitemid 47408714)
44. Gannon J, Staunton L, O'Connell K, Doran P and Ohlendieck K: Phosphoproteomic analysis of aged skeletal muscle. Int J Mol Med 22: 33-42, 2008.
45. O'Connell K, Doran P, Gannon J and Ohlendieck K: Lectin-based proteomic profiling of aged skeletal muscle: decreased pyruvate kinase isozyme M1 exhibits drastically increased levels of N-glycosylation. Eur J Cell Biol 87: 793-805, 2008.
46. Doran P, O'Connell K, Gannon J, Kavanagh M and Ohlendieck K: Opposite pathobiochemical fate of pyruvate kinase and adenylate kinase in aged rat skeletal muscle as revealed by proteomic DIGE analysis. Proteomics 8: 364-377, 2008. (Pubitemid 351212333)
47. Capitanio D, Vasso M, Fania C, Moriggi M, Vigano A, Procacci P, Magnaghi V and Gelfi C: Comparative proteomic profile of rat sciatic nerve and gastrocnemius muscle tissues in ageing by 2-D DIGE. Proteomics 9: 2004-2020, 2009.
48. Gannon J, Doran P, Kirwan A and Ohlendieck K: Drastic increase of myosin light chain MLC-2 in senescent skeletal muscle indicates fast-to-slow fibre transition in sarcopenia of old age. Eur J Cell Biol 88: 685-700, 2009.
49. Lombardi A, Silvestri E, Cioffi F, Senese R, Lanni A, Goglia F, de Lange P and Moreno M: Defining the transcriptomic and proteomic profiles of rat ageing skeletal muscle by the use of a cDNA array, 2D- and Blue native-PAGE approach. J Proteomics 72: 708-721, 2009.
50. O'Connell K and Ohlendieck K: Proteomic DIGE analysis of the mitochondria-enriched fraction from aged rat skeletal muscle. Proteomics 9: 5509-5524, 2009.
51. Donoghue P, Staunton L, Mullen E, Manning G and Ohlendieck K: DIGE analysis of rat skeletal muscle proteins using nonionic detergent phase extraction of young adult vs. aged gastrocnemius tissue. J Proteomics 7: 1441-1453, 2010.
52. Gelfi C, Vigano A, Ripamonti M, Pontoglio A, Begum S, Pellegrino MA, Grassi B, Bottinelli R, Wait R and Cerretelli P: The human muscle proteome in aging. J Proteome Res 5: 1344-1353, 2006. (Pubitemid 43865805)
53. Staunton L, O'Connell K and Ohlendieck K: Proteomic profiling of mitochondrial enzymes during skeletal muscle aging. J Aging Res 2011: 908035, 2011.
54. Ohlendieck K: Proteomic profiling of fast-to-slow muscle transitions during aging. Front Physiol 2: 105, 2011.
55. Fremont P, Charest PM, Cote C and Rogers PA: Carbonic anhydrase III in skeletal muscle fibers: an immunocytochemical and biochemical study. J Histochem Cytochem 36: 775-782, 1988.
56. Schäfer R, Knauf U, Zweyer M, Högemeier O, de Guarrini F, Liu X, Eichhorn HJ, Koch FW, Mundegar RR, Erzen I and Wernig A: Age dependence of the human skeletal muscle stem cell in forming muscle tissue. Artif Organs 30: 130-140, 2006.
57. Staunton L, Jockusch H, Wiegand C, Albrecht T and Ohlendieck K: Identification of secondary effects of hyperexcitability by proteomic profiling of myotonic mouse muscle. Mol Biosyst 7: 2480-2489, 2011.
58. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
59. Rabilloud T, Chevallet M, Luche S and Lelong C: Two-dimensional gel electrophoresis in proteomics: Past, present and future. J Proteomics 73: 2064-2077, 2010.
60. Staunton L, Jockusch H and Ohlendieck K: Proteomic analysis of muscle affected by motor neuron degeneration: the wobbler mouse model of amyotrophic lateral sclerosis. Biochem Biophys Res Commun 406: 595-600, 2011.
61. Lewis C and Ohlendieck K: Mass spectrometric identification of dystrophin isoform Dp427 by on-membrane digestion of sarcolemma from skeletal muscle. Anal Biochem 404: 197-203, 2010.
62. Shevchenko A, Tomas H, Havlis J, Olsen JV and Mann M: In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1: 2856-2860, 2006.
63. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR and Harris TB: Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21: 543-559, 2010.
64. Tan LJ, Liu SL, Lei SF, Papasian CJ and Deng HW: Molecular genetic studies of gene identification for sarcopenia. Hum Genet 131: 1-31, 2012.
65. Khaitlina SY: Functional specificity of actin isoforms. Int Rev Cytol 202: 35-98, 2001.
66. Geers C and Gros G: Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 80: 681-715, 2000. (Pubitemid 30164947)
67. Wetzel P and Gros G: Inhibition and kinetic properties of membrane-bound carbonic anhydrases in rabbit skeletal muscles. Arch Biochem Biophys 356: 151-158, 1998. (Pubitemid 28387719)
68. 2+ transient in rat skeletal muscle fibers. Am J Physiol 283: C1242-C1253, 2002.
69. Fremont P, Riverin H, Frenette J, Rogers PA and Cote C: Fatigue and recovery of rat soleus muscle are influenced by inhibition of an intracellular carbonic anhydrase isoform. Am J Physiol 260: R615-R621, 1991.
70. Brownson C, Isenberg H, Brown W, Salmons S and Edwards Y: Changes in skeletal muscle gene transcription induced by chronic stimulation. Muscle Nerve 11: 1183-1189, 1988. (Pubitemid 18263157)
71. Brownson C and Loughna P: Alterations in the mRNA levels of two metabolic enzymes in rat skeletal muscle during stretchinduced hypertrophy and disuse atrophy. Pfluegers Arch 431: 990-992, 1996. (Pubitemid 26134716)
72. Cote CH, Ambrosio F and Perreault G: Metabolic and contractile influence of carbonic anhydrase III in skeletal muscle is age dependent. Am J Physiol 276: R559-R565, 1999. (Pubitemid 29098693)
73. Wu AH and Perryman MB: Clinical applications of muscle enzymes and proteins. Curr Opin Rheumatol 4: 815-820, 1992.
74. Väänänen HK, Takala TE, Tolonen U, Vuori J and Myllylä VV: Muscle-specific carbonic anhydrase III is a more sensitive marker of muscle damage than creatine kinase in neuromuscular disorders. Arch Neurol 45: 1254-1256, 1988.
75. Brancaccio P, Lippi G and Maffulli N: Biochemical markers of muscular damage. Clin Chem Lab Med 48: 757-767, 2010.
76. Doran P, Martin G, Dowling P, Jockusch H and Ohlendieck K: Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 6: 4610-4621, 2006. (Pubitemid 44336975)
77. Mullen E and Ohlendieck K: Proteomic profiling of non-obese type 2 diabetic skeletal muscle. Int J Mol Med 25: 445-458, 2010.
78. Wallimann T, Tokarska-Schlattner M and Schlattner U: The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40: 1271-1296, 2011.
79. Yanez M, Gil-Longo J and Campos-Toimil M: Calcium binding proteins. Adv Exp Med Biol 740: 461-482, 2012.
80. Tang W, Sencer S and Hamilton SL: Calmodulin modulation of proteins involved in excitation-contraction coupling. Front Biosci 7: d1583-d1589, 2002.
81. 2+-calmodulin-dependent proteins for skeletal muscle plasticity. J Physiol 589: 5021-5031, 2011.
82. Ohlendieck K: Proteomics of skeletal muscle glycolysis. Biochim Biophys Acta 1804: 2089-2101, 2010.
83. Jensen TE and Richter EA: Regulation of glucose and glycogen metabolism during and after exercise. J Physiol 590: 1069-1076, 2012.
84. Nishimura RN and Sharp FR: Heat shock proteins and neuromuscular disease. Muscle Nerve 32: 693-709, 2005. (Pubitemid 41746258)
85. Bonifati V, Oostra BA and Heutink P: Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease. J Mol Med 82: 163-174, 2004. (Pubitemid 38392166)